1-5 of 5
Susan Bates
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ABCG2: A biomarker for the early stages of multidrug resistance in cancer cells

Anna Maria Calcagno, Jennifer Fostel, Kenneth To, Scott Martin, Katherine Chewning, Chung-Pu Wu, Susan Bates, Natasha Caplen, Suresh Ambudkar
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): A38.
Published: 15 August 2014
View article titled, ABCG2: A biomarker for the early stages of multidrug resistance in cancer cells
Journal Articles

Abstract B9: Activated MAPK Pathway Mediates Resistance to Romidepsin via Bim Degradation in Romidepsin-Selected HuT 78 Cells

Arup Chakraborty, Robert Robey, Jean-Pierre Gillet, Victoria Luchenko, Richard Piekarz, Michael Gottesman, Nathan Collie, Susan Bates
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): B9.
https://doi.org/10.1158/1078-0432.MECHRES-B9
Published: 04 March 2013
View article titled, Abstract B9: Activated MAPK Pathway Mediates Resistance to Romidepsin via Bim Degradation in Romidepsin-Selected HuT 78 Cells
Open the PDF for Abstract B9: Activated MAPK Pathway Mediates Resistance to Romidepsin via Bim Degradation in Romidepsin-Selected HuT 78 Cells in another window
Journal Articles

A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma

Hui Huang, Michael Menefee, Maureen Edgerly, Sen Zhuang, Herb Kotz, Marianne Poruchynsky, Lyn Mickley Huff, Susan Bates, Tito Fojo
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (5): 1634–1641.
https://doi.org/10.1158/1078-0432.CCR-09-0379
Published: 28 February 2010
View article titled, A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma
Open the PDF for A Phase II Clinical Trial of Ixabepilone (Ixempra; BMS-247550; NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

The Histone Deacetylase Inhibitor FK228 Preferentially Enhances Adenovirus Transgene Expression in Malignant Cells

Merrill E. Goldsmith, Masaki Kitazono, Patrick Fok, Takashi Aikou, Susan Bates, Tito Fojo
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5394–5401.
Published: 12 November 2003
View article titled, The Histone Deacetylase Inhibitor FK228 Preferentially Enhances Adenovirus Transgene Expression in Malignant Cells
Open the PDF for The Histone Deacetylase Inhibitor FK228 Preferentially Enhances Adenovirus Transgene Expression in Malignant Cells in another window
Journal Articles

Increased 99mTc-Sestamibi Accumulation in Normal Liver and Drug-resistant Tumors after the Administration of the Glycoprotein Inhibitor, XR9576

Manish Agrawal, Jame Abraham, Frank M. Balis, Maureen Edgerly, Wilfred D. Stein, Susan Bates, Tito Fojo, Clara C. Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 650–656.
Published: 01 February 2003
View article titled, Increased <sup>99m</sup>Tc-Sestamibi Accumulation in Normal Liver and Drug-resistant Tumors after the Administration of the Glycoprotein Inhibitor, XR9576
Open the PDF for Increased <sup>99m</sup>Tc-Sestamibi Accumulation in Normal Liver and Drug-resistant Tumors after the Administration of the Glycoprotein Inhibitor, XR9576 in another window